Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Chanceton Financial Group Limited Completed the Acquisition of 20% Equity Interests in Revenue Synthesis Limited

In Line with the AIDS Prevention Policy of the National 12th Five-Year Plan
The Completion of the Phase IIA of Clinical Trials of the AIDS Medication Capsule


Hong Kong, Dec 7, 2012 - (ACN Newswire) - Chanceton Financial Group, an one-Stop integrated and diversified financial services company, ("Chanceton" or the "company" stock code: 8020, the company and its subsidiaries collectively called the "Group") is pleased to announce that with the reference of the announcement of the Company dated 24 August 2012 in relation to the acquisition of 20% equity interests in Revenue Synthesis Limited relating to AIDS medication business, with all conditions precedent under the Sale and Purchase Agreement dated 24 August 2012 had been fulfilled, the completion has been taken place on 5 December 2012.

The Board is also pleased to announce that the Phase IIa of the clinical trials of the AIDS Medication Capsule was completed on 23 September 2012 and the results of such clinical trial reports published by relevant hospitals was satisfied by the Purchaser at its absolute discretion on 5 December 2012. In conclusion, Phase IIa has showed that the AIDS Medication Capsule has significant effect on suppressing the viral replication of HIV/AIDS virus and is effective and safe for HIV/AIDS therapy. The study also shows that middle-dose is the most effective dosage for the therapy. As a result, Beijing Century Health will proceed to Phase IIb, aiming to further assess the efficacy and safety of the specified dosage (middle-dose) of AIDS medicine on HIV/AIDS patients.

According to the "China AIDS Epidemic Assessment Report 2011" announced by the Chinese Ministry of Health in 2012, as of the end of 2011, it is estimated that 780,000 people are living with HIV /AIDS in China and 48,000 new HIV infected patients. Since the forming of the AIDS prevention working committee and institution in China in 2004, the funding for AIDS prevention has been increasing in recent years, from RMB 1.2 billion in 2002 up to RMB 23.9 billion in 2012. The World AIDS Day 2012, held on 1 December every year, has recently taken place; the PRC leaders expressed great awareness to this year's event. In the "12th Five-Year AIDS Suppression and Prevention Action Plan", it mentioned the expansion of medication coverage, the enhancement of medication quality and accessibility of treatment in order to cope with the challenges, posed by the entering of the stage that occurring symptoms in domestic AIDS patients, the increasing in the difficulties of AIDS prevention, the increasing risk of transmission and the increasing demand of medication funding.

"This herbal AIDS medicine invented by Beijing Century Health, coupled with clinical trials matching the Western standard, is the first Chinese medicine for AIDS medication in China. In line with the AIDS prevention policy of the National 12th Five-Year Plan, we believe that it has high growth potential in China and over the world. Through this strategic acquisition, we are able to maximize our shareholders' value. The result of the Phase IIa of clinical trials has been encouraging and we are looking forward to a more arousing result from Phase IIb.", says Mr. Wong Kam Wah, the chairman of the Group.



Copyright 2012 ACN Newswire. All rights reserved.

About ACN Newswire
Copyright 2008 ACN Newswire. All rights reserved. Republication or redistribution of ACN Newswire content is expressly prohibited without the prior written consent of ACN Newswire. ACN Newswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
One look at the comments section of an April column on digital marketing in TechCrunch, and it becomes obvious that contributor Samuel Scott, the marketing and communications director for data analytics software firm Logz.io, pushed a few hot buttons with his take on marketing tech. S...
The current version of Angular is Release Candidate 1. This version changed the way how the framework is distributed – it comes as a set of scoped npm packages now. Any imports of the Angular classes will be done from @angular instead of angular2, for example: import {bootstrap} from ...
Cloud computing changed data analytics for good. It enabled companies to drastically decrease resources and architecture previously assigned with business intelligence departments. It also enabled laymen to run advanced business analytics. Cloud was also the architecture of choice for ...
Are you evaluating a software asset for a potential purchase, investment, decision making for the future, possible termination, etc? Here are some questions to consider. Is this a revenue generating asset? How much revenue does it generate? - Establishing the true business value of a...
If the cloud was once (ever) bleeding edge, now the cloud is sheer necessity for anyone doing anything on the Internet. It has changed the way we architect applications, build IT budgets, grow userbases, even write individual lines of code. As the Internet continues to lambdify, cloud ...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE